NCT07735585

Brief Summary

Alcohol Use Disorder (AUD) is a major public health concern associated with substantial morbidity, mortality, and impaired social and occupational functioning. Contingency Management (CM) is an evidence-based behavioral intervention that provides incentives contingent on abstinence and has demonstrated effectiveness in the treatment of substance use disorders. This study will evaluate the efficacy of Tratamento Remoto com Incentivos à Sobriedade (TRIS), a Brazilian mobile health application that integrates a smartphone app with a Bluetooth-enabled breathalyzer (BACtrack) to deliver remote CM for AUD. Participants will be randomized to receive either standard outpatient treatment plus TRIS-based CM or standard outpatient treatment with remote alcohol monitoring only. The primary objective is to determine whether TRIS-based CM increases biochemically verified alcohol abstinence compared with standard outpatient treatment alone.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
17mo left

Started Feb 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress25%
Feb 2026Dec 2027

First Submitted

Initial submission to the registry

December 15, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

February 19, 2026

Completed
5 months until next milestone

First Posted

Study publicly available on registry

July 30, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

July 30, 2026

Status Verified

December 1, 2025

Enrollment Period

1.4 years

First QC Date

December 15, 2025

Last Update Submit

July 27, 2026

Conditions

Keywords

Alcohol Use DisorderContingency ManagementSobriety

Outcome Measures

Primary Outcomes (1)

  • Days of Alcohol Abstinence

    Number of days with verified abstinence based on three daily BrAC samples submitted via the BACtrack remote breathalyzer over the 12-week intervention period.

    Up to 12 weeks

Secondary Outcomes (5)

  • Days without Heavy Alcohol Consumption

    Up to 12 weeks

  • App Usability

    Week 12 (end of intervention)

  • Clinical Institute Withdrawal Assessment for Alcohol, Revised (CIWA-Ar)

    Baseline (Week 0), weekly during Weeks 1-12, and follow-up at Weeks 16, 20, and 24.

  • Obsessive-Compulsive Drinking Scale (OCDS)

    Baseline (Week 0), weekly during Weeks 1-12, and follow-up at Weeks 16, 20, and 24.

  • Treatment Adherence

    Up to 12 weeks

Study Arms (2)

Contingency Management (CM) + Treatment as Usual (TAU)

EXPERIMENTAL

Participants receive standard outpatient treatment plus 12 weeks of remote contingency management delivered through the TRIS mobile application. Participants submit three breath alcohol concentration (BrAC) samples daily using a Bluetooth-enabled breathalyzer and receive escalating monetary incentives contingent on alcohol-negative breath samples.

Behavioral: Remote Contingency Management (CM)

Treatment as Usual (TAU)

ACTIVE COMPARATOR

Participants receive standard outpatient treatment for Alcohol Use Disorder and use the TRIS mobile application to submit three daily breath alcohol concentration (BrAC) samples using a Bluetooth-enabled breathalyzer. No monetary incentives are provided for alcohol-negative breath samples.

Behavioral: Treatment as Usual (TAU)

Interventions

Remote contingency management delivered through the TRIS mobile application. Participants submit three daily breath alcohol concentration (BrAC) samples using a Bluetooth-enabled BACtrack breathalyzer. Monetary incentives ranging from R$5.00 to R$15.00 per day are provided contingent on verified alcohol abstinence.

Contingency Management (CM) + Treatment as Usual (TAU)

Standard outpatient treatment for Alcohol Use Disorder provided at the participating outpatient clinics. Participants also use the TRIS mobile application and a Bluetooth-enabled BACtrack breathalyzer for remote alcohol monitoring but do not receive contingency management incentives.

Treatment as Usual (TAU)

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to read and speak Portuguese.
  • Provide signed informed consent.
  • Age 18 to 70 years.
  • Alcohol consumption within the past month.
  • Current diagnosis of Alcohol Use Disorder (AUD).
  • Seeking treatment for AUD at AME Vila Maria or Instituto Perdizes.
  • Breath alcohol concentration (BrAC) of 0.00 at the time of consent.
  • Own and be able to operate a smartphone with an active mobile service plan.
  • Smartphone compatible with the Bluetooth frequency required for the BACtrack breathalyzer.

You may not qualify if:

  • Crack cocaine use within the past 90 days.
  • Any seizure episode within the past 12 months.
  • Diagnosis of a psychotic disorder (DSM-5).
  • Suicide attempt within the past two years.
  • Any medical or psychiatric condition that may compromise safe participation, as determined by the study medical director.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IPER Research Center

São Paulo, São Paulo, 05021-001, Brazil

RECRUITING

MeSH Terms

Conditions

Alcoholism

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • André Miguel, PhD

    Washington State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Vinicius Soares, PhD

CONTACT

Aline Camargo Ramos, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomized in a 1:1 ratio to receive either standard outpatient treatment plus remote Contingency Management (CM) delivered through the TRIS mobile application or standard outpatient treatment with remote alcohol monitoring without contingency management incentives.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2025

First Posted

July 30, 2026

Study Start

February 19, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

July 30, 2026

Record last verified: 2025-12

Locations